User:esmeewpvi689536

The drug is a emerging therapeutic specific to CD22, the cell protein present primarily on Immune lymphocytes . This process of effect consists of inhibiting CD22-mediated

https://liviaevgf840375.pointblog.net/epratuzumab-a-deep-dive-into-the-cd22-antibody-treatment-93398575